The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
- 1 May 1999
- journal article
- review article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 33 (3) , 181-214
- https://doi.org/10.1016/s0022-3956(98)90056-5
Abstract
No abstract availableKeywords
This publication has 206 references indexed in Scilit:
- Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in ratsCellular and Molecular Neurobiology, 1994
- Corticotropin-Releasing Factor Stimulates Ca2+ Influx in Cultured Rat AstrocytesBiochemical and Biophysical Research Communications, 1994
- Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptorsFEBS Letters, 1993
- High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitizationBrain Research, 1993
- Stress updateTrends in Endocrinology & Metabolism, 1993
- CSF somatostatin in Alzheimer's disease and major depression: Relationship to hypothalamic-pituitary-adrenal axis and clinical measuresPsychoneuroendocrinology, 1993
- Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptorCell, 1990
- cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatmentEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjectsLife Sciences, 1985
- Intraventricular corticotropin-releasing factor enhances behavioral effects of noveltyLife Sciences, 1982